Metabolism and Target Organ Damage

Metabolism and Target Organ Damage (M&TOD) is an international, peer-reviewed, open access interdisciplinary journal which provides an online platform for publication of clinical, basic and translational studies. It covers (cardio)-metabolic disorders per se, such as obesity, diabetes, dyslipidemias, arterial hypertension and hyperuricemia in all age groups. Of note, this journal will emphasize the role of these metabolic disorders as either effectors/amplifiers or consequences of the development and progression of injuries to target organs including but not limited to the cardiovascular system, the liver, kidneys and the pancreas. Specific applications in metabolic disorders are as follows: history of disease, epidemiology, prevention, natural history, genetics, cell and molecular biology, pathobiochemistry, physiopathology, anatomic pathology, clinical chemistry, pharmaceutical chemistry, pharmacology, psychology, psychiatry, statistics and immunology.

From a clinical point of view, the journal covers aspects of biomarkers, diagnosis, prognosis and all types of innovative management strategies including cognitive-behavioral approaches and randomized controlled trials of innovative drug schedules of metabolic disorders. M&TOD welcomes to publish researches to promote the development of animal-free models of studies including cell cultures, artificial intelligence and others.

M&TOD particularly welcomes studies of translational value of ranging from basic science to clinical applications which is interested in evaluating submissions pertaining to all areas of public health including health policy; health economics, internal medicine and its sub-specialties, such as cardiology, endocrinology hepato-gastroenterology, nephrology, oncology, general surgery and its branches such as bariatric, endocrine, vascular, metabolic, oncological surgery.

M&TOD accepts submissions of the following editorial categories: Original Article, Review, Case Report, Commentary, Mini-Review, Systematic Review, Meta-analysis, Editorial, Perspective, Opinion, Communication, Letter and Research Highlight.